2025-09-05 |
13D/A |
VALN / Valneva SE - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
21,810,176 |
11.60 |
54.53 |
2025-09-02 |
13D/A |
SNTI / Senti Biosciences, Inc. |
Celadon Partners SPV 24 |
13,404,441 |
45.00 |
37.10 |
2025-08-29 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
36,884,567 |
29.10 |
-5.36 |
2025-08-26 |
13D/A |
IVVD / Invivyd, Inc. |
M28 Capital Management LP |
9,548,250 |
4.60 |
3.24 |
2025-08-19 |
13D/A |
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) |
New Enterprise Associates 14, L.P. |
4 |
0.00 |
-100.00 |
2025-08-18 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Commander Aggregator, LP |
7,788,150 |
4.50 |
|
2025-08-15 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Orbimed Advisors Llc |
15,219,994 |
8.90 |
0.00 |
2025-08-14 |
13D/A |
ACLX / Arcellx, Inc. |
New Enterprise Associates 15, L.P. |
3,055,360 |
5.51 |
-18.42 |
2025-08-14 |
13D/A |
SLDB / Solid Biosciences Inc. |
Ra Capital Management, L.p. |
7,997,510 |
9.90 |
|
2025-08-12 |
13D/A |
ARMP / Armata Pharmaceuticals, Inc. |
Innoviva, Inc. |
55,467,459 |
83.30 |
-13.57 |
2025-08-11 |
13D/A |
CDTX / Cidara Therapeutics, Inc. |
Ra Capital Management, L.p. |
3,365,523 |
13.30 |
0.00 |
2025-07-31 |
13D/A |
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock) |
Sofinnova Crossover I |
9,599,478 |
11.40 |
23.16 |
2025-07-24 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
132,473 |
4.25 |
-45.68 |
2025-07-21 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
243,878 |
7.82 |
-95.88 |
2025-07-09 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
5,923,534 |
9.50 |
-10.92 |
2025-07-09 |
13D/A |
VOR / Vor Biopharma Inc. |
5AM Ventures VI, L.P. |
4,422,863 |
3.50 |
-30.48 |
2025-07-03 |
13D/A |
FATE / Fate Therapeutics, Inc. |
Redmile Group, LLC |
17,941,579 |
14.90 |
0.70 |
2025-06-30 |
13D/A |
KYMR / Kymera Therapeutics, Inc. |
Baker Bros. Advisors Lp |
6,666,540 |
9.50 |
11.09 |
2025-06-30 |
13D/A |
CDTX / Cidara Therapeutics, Inc. |
Ra Capital Management, L.p. |
3,365,523 |
15.80 |
207.97 |
2025-06-27 |
13D/A |
VOR / Vor Biopharma Inc. |
Ra Capital Management, L.p. |
39,739,850 |
31.80 |
0.08 |
2025-06-23 |
13D/A |
ENZN / Enzon Pharmaceuticals, Inc. |
Icahn Carl C |
36,056,636 |
48.60 |
0.00 |
2025-06-20 |
13D/A |
CASI / CASI Pharmaceuticals, Inc. |
He Wei-Wu |
3,735,535 |
23.80 |
14.66 |
2025-06-09 |
13D/A |
PLUR / Pluri Inc. |
Chen Franco-Yehuda |
40,064 |
0.51 |
|
2025-06-05 |
13D/A |
PROK / ProKidney Corp. |
Tolerantia, LLC |
106,901,339 |
36.50 |
-3.45 |
2025-06-03 |
13D/A |
TSHA / Taysha Gene Therapies, Inc. |
Manning Paul B |
25,601,111 |
9.80 |
9.05 |
2025-06-02 |
13D |
NKGN / NKGen Biotech, Inc. |
CFIC-2015 NV Family Investments, LLC |
63,175,321 |
47.20 |
1,416.21 |
2025-05-28 |
13D |
ZURA / Zura Bio Limited |
AI Biotechnology LLC |
14,326,090 |
19.90 |
|
2025-05-28 |
13D/A |
OTLK / Outlook Therapeutics, Inc. |
GMS Ventures & Investments |
29,040,929 |
50.30 |
79.44 |
2025-05-23 |
13D |
ATRA / Atara Biotherapeutics, Inc. |
Redmile Group, LLC |
705,207 |
9.90 |
17.29 |
2025-05-22 |
13D |
BCDA / BioCardia, Inc. |
Blank Andrew Scott |
278,253 |
5.50 |
|
2025-05-21 |
13D/A |
BCDA / BioCardia, Inc. |
Daly Joseph Patrick |
|
|
|
2025-05-20 |
13D/A |
PLUR / Pluri Inc. |
Yanay Yaky |
484,866 |
6.00 |
-94.57 |
2025-05-20 |
13D/A |
EXEL / Exelixis, Inc. |
Farallon Capital Partners, L.P. |
18,635,500 |
6.80 |
-20.50 |
2025-05-19 |
13D/A |
AURA / Aura Biosciences, Inc. |
Matrix Capital Management Company, LP |
6,922,870 |
11.17 |
0.00 |
2025-05-14 |
13D/A |
TNYA / Tenaya Therapeutics, Inc. |
Column Group Iii, Lp |
49,313,559 |
30.30 |
0.00 |
2025-05-12 |
13D |
NKGN / NKGen Biotech, Inc. |
Paul Y. Song |
63,738,042 |
54.30 |
|
2025-05-12 |
13D/A |
ACLX / Arcellx, Inc. |
New Enterprise Associates 15, L.P. |
3,745,262 |
6.80 |
0.00 |
2025-05-08 |
13D/A |
INAB / IN8bio, Inc. |
BIOS Fund II, LP |
9,120,073 |
9.99 |
-12.44 |
2025-05-02 |
13D |
HLVX / HilleVax, Inc. |
Tang Capital Management Llc |
4,920,000 |
9.80 |
|
2025-04-25 |
13D/A |
PASG / Passage Bio, Inc. |
Orbimed Advisors Llc |
6,650,000 |
10.70 |
-10.19 |
2025-04-25 |
13D |
CRBU / Caribou Biosciences, Inc. |
Haurwitz Rachel E. |
4,716,003 |
5.00 |
7.70 |
2025-04-21 |
13D/A |
IMVT / Immunovant, Inc. |
Roivant Sciences Ltd. |
96,660,341 |
56.90 |
0.00 |
2025-04-11 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Orbimed Advisors Llc |
15,219,994 |
11.00 |
-19.01 |
2025-04-07 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
17,455,376 |
12.20 |
144.07 |
2025-03-31 |
13D/A |
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock) |
Baker Bros. Advisors Lp |
23,489,663 |
17.10 |
-0.00 |
2025-03-31 |
13D/A |
ABOS / Acumen Pharmaceuticals, Inc. |
Ra Capital Management, L.p. |
15,016,063 |
24.80 |
0.23 |
2025-03-28 |
13D/A |
SRZN / Surrozen, Inc. |
Column Group Iii Gp, Lp |
3,407,405 |
34.00 |
169.30 |
2025-03-17 |
13D/A |
SNTI / Senti Biosciences, Inc. |
Celadon Partners SPV 24 |
9,777,000 |
37.60 |
0.00 |
2025-03-13 |
13D/A |
ELUT / Elutia Inc. |
HighCape Capital, L.P. |
9,611,039 |
26.40 |
4.57 |
2025-03-13 |
13D |
SNTI / Senti Biosciences, Inc. |
Celadon Partners SPV 24 |
9,777,000 |
37.60 |
|